Skip to content

7 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Clinical and genetic correlates of a circadian subtype of depression in the Australian Genetics of Depression Study.

Findings support the face validity and potential clinical utility of a circadian subtype of depression as a clinical profile and support the face validity and potential clinical utility of its biology and predictive utility.

E. Tonini, J. Crouse, M. Shin et al. · 1 citation
Sep 2026

An Internal-Standard-Integrated Digital SERS Immunoassay for Accurate and Precise Trace-Level Cytokine Quantification in Plasma

Accurate and precise quantification of trace-level cytokines in complex biological matrices remains challenging, limiting their use as longitudinal biomarkers in clinical studies. Here, we present a nanotechnology-enabled surface-enhanced Raman scattering (SERS) platform incorporating an internal standard (IS) for di...

Yi-Wen Zhang, Fahimeh Farokhinejad, Jacob J. Crouse et al. · 0 citations
Open access Oct 2026

Association between polygenic liability to depression and lifetime depression in at-risk adolescents.

Internalising symptoms including depression, anxiety and somatic symptoms in adolescence are common. They can be transient, but they can also persist and progress to major depressive disorder (MDD) Polygenic risk scores for major depression (MD-PGS) may help identify which symptomatic adolescents are at greatest risk o...

E. Byrne, Nathan A. Gillespie, J. Najman et al. · 0 citations
Open access Sep 2026

Polygenic effects on cortical size and ADHD converge on a mid-gestational progenitor-to-neuron transition programme

Neurodevelopmental and psychiatric conditions have long been hypothesised to emerge from changes in the structure and function of the brain. However, the molecular and cellular mechanisms linking brain structure to these conditions remain unknown. Here, using genetic and structural/diffusion neuroimaging data from 59,2...

Y. He, A. Ebneabbasi, K. Rademaker et al. · 0 citations
Open access Sep 2026

260. Prescription medication use, healthcare utilisation and genetic risk for addiction: a phenome-wide association and Mendelian randomization study

Abstract Background Substance Use Disorders (SUDs) are major contributors to global morbidity and premature mortality. While their adverse physical and psychiatric sequalae are widely attributed to toxic effects of substance exposure, accumulating evidence suggests that inherited liability to addiction also shapes broa...

M. Graczyk, C. Albiñana, A. Lee et al. · 0 citations
Open access Aug 2026

Polygenic and familial contributions to antidepressant continuation, switching, discontinuation and augmentation in the All of Us and Pharmlines cohorts

Antidepressant switching partly indexes depression severity rather than drug-specific non-response alone, whereas augmentation captures cross-disorder psychiatric complexity, and familial aggregation was confined to sustained, switch-free continuation.

A. Walker, X. Wang, J. Bos et al. · 0 citations
#machine learning Preprint Aug 2026

Learning Human Health and Diseases from 24-hour Wrist Movement

These findings establish 24-hour wrist movement as a rich and scalable source of health information, with the potential to support passive health monitoring and disease prediction at population scale, and establish Sensori, a self-supervised foundation model that learns general-purpose health representations directly f...

Yong Wang, D. McGagh, K. Broomberg et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.